Health & Medicine
6 items
Bound by the Phone: The Structure That Distorts Nursing Labor Quality and Time Allocation
A nurse's primary work is direct patient care. Yet international time-motion studies have repeatedly shown that direct care occupies only 20-38% of total nursing work time. The remainder is consumed by documentation and coordination, especially the relentless phone calls to chase down family signatures within seven days. Starting from a Hyogo Prefecture case reported by FIRST-HAND Local in April 2026, this column layers Japan's MHLW research findings (daily nursing records are the leading cause of overtime), the operational gap of the Discharge Support Add-on A246 7-day requirement, and the Dutch Buurtzorg model record only what is meaningful principle to re-read nursing labor quality from the institutional design side.
Japan's Late-Elderly Medical Premium Cap Raised from ¥800K to ¥850K (FY2026): Pinpoint Increase on the Top 1.2% and Its Spillover to Middle and Lower Incomes
On December 12, 2025, the Health Insurance Subcommittee of Japan's Social Security Council approved a plan to raise the annual premium cap for the late-elderly medical care system from ¥800K to ¥850K starting FY2026, with a new ¥21K Child-Care Support Levy portion added separately from April 2026, bringing the combined cap to ¥871K. The increase targets enrollees with annual pension-plus-salary income of ¥11.5M or more — approximately 1.2% of all enrollees. Headlines read "premiums rise for the 75-plus generation," but the institutional logic is different: a pinpoint cap increase on the top 1.2% slows premium growth for the remaining 98.8%. A model case at ¥4M annual income shows FY2026 premiums of about ¥297K (+4.2% year-over-year). This article unpacks the MHLW design, the meaning of "1.2% of enrollees," the new ¥21K Child-Care Support Levy, and the often-conflated distinction between intra-generational ability-based redistribution and inter-generational benefit structure.
The Polypharmacy Problem in Japan's Elderly — Why 40% Take 5 or More Medications
About 40% of Japanese adults aged 75+ are prescribed 5 or more medications, and roughly 25% take 7 or more. Once the threshold of 6 drugs is crossed, adverse drug events increase significantly. Prescribing cascades, fragmented care, and psychological barriers to deprescribing perpetuate this structural problem.
Is Noise 'Invisible Violence'? — Health Risks Warned by the WHO and Japan's Regulatory Vacuum
A disease burden of 1.6 million DALYs annually attributable to noise represents a level that cannot be overlooked. Cardiovascular disease, sleep disorders, cognitive impairment — the WHO ranks noise as the 'second-largest environmental risk factor after air pollution.' This article examines, through data, both the international comparison of Japan's regulatory standards and the actual extent of health harm caused by noise.
The Economic Rationality of Preventive Medicine: Social Design in the Era of 48 Trillion Yen Healthcare Costs
Structural analysis of the cost-effectiveness of preventive medicine investment. Comparing healthcare expenditure breakdown and preventive ROI.
The Structure of ¥48 Trillion in Medical Expenses — A Turning Point for Sustainability Toward 2030
Japan's medical expenses hit ¥48.09 trillion in FY2023—a record high. As spending grows relentlessly, the healthcare system faces sustainability challenges.